News & Publications

The USPTO has announced that Phase 1 of its Access to Relevant Prior Art (RPA) Initiative will begin Nov. 1, 2018.

The USPTO has published a Request for Comments (RFC) on a proposed procedure for motions to amend filed in AIA trials before the PTAB.

Registration is now open for the Feb. 5 - 7, 2019 USPTO Inventor 3-Day Course on Examination Practice and Procedure.

The Federal Circuit on October 12, 2018, affirmed a district court decision invalidating Teva’s patents for Copaxone, its best-selling multiple sclerosis drug.

The Supreme Court on October 15, 2018, declined to review a Federal Circuit decision affirming a district court’s holding that two of Two-Way Media Ltd.’s patents directed to internet streaming of video and audio were ineligible for protection.

The US Court of Appeals for the First Circuit on October 15, 2018, reversed a district court order certifying a class of indirect purchasers of the drug Asacol to pursue antitrust claims against Allergan Inc., the drugmaker.

Congress recently passed the Orrin G. Hatch–Bob Goodlatte Music Modernization Act, which the president signed into law on October 11, 2018.

On October 9, 2018, President Donald J. Trump signed into law S. 2559, the “Marrakesh Treaty Implementation Act,” which provides for the implementation of the Marrakesh Treaty to Facilitate Access to Published Works for Persons Who Are Blind, Visually Impaired or Otherwise Print Disabled.

The final rule replaces the "broadest reasonable interpretation" standard with the federal court claim construction standard, also known as the Phillips standard, that is used to construe a claim in a civil action under 35 U.S.C. § 282(b).

On September 10, 2018, the United States Court of Appeals for the Federal Circuit upheld the Patent Trial and Appeal Board’s decision to invalidate IXI IP LLC’s patent related to sharing an internet connection over Bluetooth because it’s obvious in light of prior inventions.